期刊文献+

转化生长因子β_2在乳腺癌中的表达及其预后意义

暂未订购
导出
摘要 目的 研究转化生长因子β_2(TGFβ_2)在乳腺癌中的表达及其与乳腺癌预后的关系。方法 对86例随访5年以上乳腺癌用免疫组化法检测TGFβ_2蛋白表达。结果 TGFβ_2蛋白表达与乳腺癌肿瘤大小、组织学分级无明显相关性,而与腋淋巴结转移状况显著相关。与乳腺癌预后呈负相关,TGFβ_2阳性度越高,乳腺癌术后5年生存率越低。结论 TGFβ_2是乳腺癌预后不良因素之一,临床检测乳腺癌FGFβ_2蛋白表达可作为乳腺癌生物学行为和预后判断的指标。
出处 《实用肿瘤学杂志》 CAS 2000年第3期185-187,共3页 Practical Oncology Journal
  • 相关文献

参考文献8

  • 1[1]Leof EB,Proper JA,Goustin AS et al. Identification of C-sis mRNA and activity similar to platelet-derived growth factor by transforming growth factor β:A proposed model for indirect mitogenesis involving autocrine activity. Proc Natl Acad Sci USA,1986;83:2453
  • 2[2]Laiho M,SeCaprio JA,Ludlow JW,et al. Growth inhibition by TGF-β linked suppresion of retinoblastoma protein phosphorylation. Cell ,1990;62:175
  • 3[3]Kehl JH,Poberts AB,Wakefield LM,et al. Transforming growth factor β is an important immunomodulatory protein for human B lymphocytes . J Immunol, 1986 ; 37 : 3855
  • 4[4]Torre-Aminone G,Beauchamp RD,Koeppen H,et al. A highly immunogenic tumor transformed with a murine transforming growth factor type β cDNA escapes immune surveillance. Proc Natl Acad Sci USA,1990;87:1486
  • 5[5]Arteaga CL, Tandon AK, Von Hoff DD et al. Transforming growth factor β:A potential autocrine growth inhibitor of estrogen receptor- negative human breast cancer cells. Cancer Res,1988;48:3898
  • 6[6]Daly RJ,King RJ,Darbre PD. Interaction of growth factors during progression towards steroids independence in T47D human breast cancer cells. J Cell Biochem, 1990 ; 43:199
  • 7[7]Barrett - Lee P, Travers M, Luqmani Y, et al. Transcripts for transforming grwoth factors in human breast cancer :clinical correlates. Br J Cancer, 1990 ; 61: 612
  • 8[8]Ko y,Banerji ss,Liu Y et al. Expression of transforming growth factor-beta receptor type Ⅱ and tumorigenicity in human breast adenocarcinoma MCF- 7 cells. J Cell Physiol, 1998; 176:424

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部